Occlusion therapy of unilateral amblyopia with botulinum toxin induced ptosis

Seminars in Ophthalmology

Volumn 22, Issue 1, 2007, Pages 55-57

  Halkiadakis, Ioannis ^a   Iliaki, Olga ^a   Kalyvianaki, Maria I ^a   Tsilimbaris, Miltiadis K ^a,b  

^a Technological Institute of Heraklion   (Greece)

^b Department of Ophthalmology   (Greece)

Author keywords

Amblyopia; Botulinum; Temporary ptosis; Uncooperative children

Indexed keywords

BOTULINUM TOXIN A; CYCLOPLEGIC AGENT;

ACCOMMODATION PARALYSIS; AMBLYOPIA; ARTICLE; CASE REPORT; EXTRAOCULAR MUSCLE; EYELID CLOSURE; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PTOSIS; VISUAL ACUITY;

AMBLYOPIA; ANTI-DYSKINESIA AGENTS; BLEPHAROPTOSIS; BOTULINUM TOXINS; CHILD, PRESCHOOL; EYELIDS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; MALE; SENSORY DEPRIVATION; VISUAL ACUITY;

EID: 33847690670     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.1080/08820530601182709     Document Type: Article

References (5)

1. Ansons AM, Davis H. Diagnosis and Management of Ocular Motility Disorders, 3rd ed. Oxford: Blackwell Science. 2001; 213-228.
2. Crouch ER, Theobald TA , Lattanzio FA, et al. Botulinum toxin-induced ptosis as treatment for childhood amblyopia. Invest Ophthalmol Vis Sci 2004;45: E-Abstract 4995.
3. Kirkness CM, Adams GG, Dilly PN, Lee JP. Botulinum toxin A-induced protective ptosis in corneal disease. Ophthalmology 1988;95(4):473-80.
4. Ellis MF, Daniell M. An evaluation of the safety and efficacy of botulinum toxin type A (BOTOX) when used to produce a protective ptosis. Clin Experiment Opthalmol 2001;29(6):394-99.
5. Wrigh KW, Spiegel PH, eds. Pediatric ophthalmology and strabismus. In: Krachmer JH (ed.) The Requisites in Ophthalmology. St. Louis: Mosby (1999), 207.